Identification of Amyloidogenic Light Chains Requires the Combination of Serum-Free Light Chain Assay with Immunofixation of Serum and Urine - Wikidata - wikimedia - TriplyDB

Identification of Amyloidogenic Light Chains Requires the Combination of Serum-Free Light Chain Assay with Immunofixation of Serum and Urine

Identification of Amyloidogenic Light Chains Requires the Combination of Serum-Free Light Chain Assay with Immunofixation of Serum and Urine

http://www.wikidata.org/entity/Q58030328

about

Immunoglobulin light chain amyloidosis: 2013 update on diagnosis, prognosis, and treatment Paraprotein-Related Kidney Disease: Diagnosing and Treating Monoclonal Gammopathy of Renal Significance.Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment.Early reduction of serum-free light chains associates with renal recovery in myeloma kidney.Amyloidosis: pathogenesis and new therapeutic options.Primary systemic amyloidosis as a real diagnostic challenge - case study.The utility of MASS-FIX to detect and monitor monoclonal proteins in the clinic.A phase II trial of cyclophosphamide, lenalidomide and dexamethasone in previously treated patients with AL amyloidosis.Screening panels for detection of monoclonal gammopathies.Current trends in the diagnosis, therapy and monitoring of the monoclonal gammopathies.Oral melphalan and dexamethasone grants extended survival with minimal toxicity in AL amyloidosis: long-term results of a risk-adapted approach.Serum free light chain analysis in multiple myeloma and plasma cell dyscrasias.Immunoglobulin light chain amyloidosis: 2011 update on diagnosis, risk-stratification, and management.How to diagnose amyloidosis.Serum free light chain analysis in the diagnosis and management of multiple myeloma and related conditions.Immunoglobulin light chain amyloidosis.The use of immunoglobulin light chain assays in the diagnosis of paraprotein-related kidney disease.Audit of Use and Overuse of Serum Protein Immunofixation Electrophoresis and Serum Free Light Chain Assay in Tertiary Health Care: A Case for Algorithmic Testing to Optimize Laboratory Utilization.Systemic amyloidosis: novel therapies and role of biomarkers.Serum-free light-chain analysis in diagnosis and management of multiple myeloma and related conditions.Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies.Immunoglobulin light chain amyloidosis: 2016 update on diagnosis, prognosis, and treatment.Capillary electrophoresis/immunosubtraction as a better alternative to immunofixation for detecting and immunotyping serum monoclonal proteins in patients with immunoglobulin light chain (AL) amyloidosis.Comparison of Fully Automated and Semiautomated Systems for Protein Immunofixation Electrophoresis.Immunoglobulin heavy light chain test quantifies clonal disease in patients with AL amyloidosis and normal serum free light chain ratio.Serum Free Light Chain Assay and κ/λ Ratio: Performance in Patients With Monoclonal Gammopathy-High False Negative Rate for κ/λ Ratio Quantitative serum free light chain assay--analytical issues.Screening panels for monoclonal gammopathies: time to change Amyloidosis: an unusual cause of portal hypertension.Monoclonal gammopathies--clinical and laboratory issues.New concepts in the treatment and diagnosis of amyloidosis.Best use of cardiac biomarkers in patients with AL amyloidosis and renal failure.Urine immunofixation electrophoresis remains important and is complementary to serum free light chain.Oligosecretory Myeloma With Amyloidosis and Alopecia.Identification and quantification of urinary monoclonal proteins by capillary electrophoresis in AL amyloidosis.Serum Free Light Chain Assay and κ/λ Ratio Performance in Patients Without Monoclonal Gammopathies: High False-Positive Rate.Light Chain Amyloidosis.Abstracts Primary Systemic Amyloidosis (AL)Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: a matched case–control study on 174 patients

P2860

Q26827340-89B01B7A-3AFE-47BD-ABBB-561C6266BFFE Q30276115-FFEDCAEC-C1AD-4800-A445-82B5BC5C740F Q34448455-C25578B5-C033-4EB9-910E-B7A0D8797FBD Q35012436-BCAC3E5A-3B37-49E0-82EA-AA7EF92F0B52 Q35111771-268F1EA8-6FD7-40BB-B98A-980BB6CA69BB Q35631725-FE502B41-D221-4C22-80E7-C841891B2D2E Q36356006-DEF5E028-CC83-4F5B-8647-CFB047CB425D Q36862339-882BDCEC-B299-4DA8-8DCE-F03115F39D41 Q37172007-740B4DA9-EAE2-4339-A739-63FC540AD11F Q37370051-EA78B91D-59A9-4C76-B144-868A40435ADF Q37676296-580BC75C-98B0-42B4-A83E-109B2B17CE56 Q37821496-F27DDD6E-931C-48B7-83E0-A98459FF74FF Q37832199-21F56F9A-298B-4F4A-8C6F-F59FF5B667C2 Q38136289-EE637DEA-D12A-48A4-8149-A20A401E1EE4 Q38168869-9F4E56F9-0ABC-41E5-B16E-B15AEC532364 Q38172295-BFF59935-1FB6-43A7-9361-07CC474CFA1D Q38258148-3DC9C455-D803-42BA-A5EE-60DDEAD561E1 Q38819967-1A9D7905-E6E5-4E4A-BFF4-6863139EFE3E Q38829923-3C7A822B-43E8-48F0-A40A-24D32FA538E4 Q38911216-16396A98-1E26-4D3F-9067-4F0761275C72 Q38917341-28DFC0A5-14D3-46C2-B2F3-A57C17999533 Q38928383-3EE95657-F0B3-4569-B8BC-CAAE1832C88D Q39341586-5E3D0FEF-F044-44C2-88AB-A79971680CB6 Q39594256-3C0A374D-A976-4447-9C7D-98235769AF02 Q40563598-A8C85F71-48D0-44EF-BD7A-94C7F8CB6DB1 Q41896714-FC52583D-145C-44EE-BA72-000F8171668B Q41994443-2C718D05-CA78-4DE8-8AA9-122D6A5FC0F1 Q42098619-C5464CE7-4EDB-4FF3-B9E6-14402B5B9EEC Q42360655-107B778D-0CAF-4A66-AC80-458CCCC6D773 Q42574085-F987F70B-749F-45A1-8103-E929E4F857D8 Q47561519-D3F79D8A-BF3D-4DF0-8984-C28A4A758A45 Q48629376-FA40F212-9E2F-4165-8D02-CB79E16C2EA8 Q48853691-283FE0D0-3F80-43E7-906C-C73F8927CAE0 Q49218963-23180A30-85FD-4811-9359-C2FB977BB947 Q51039671-B1D31AFC-B8D7-4A7D-A251-677D7FB2DF10 Q51606154-5802B7D2-B313-4DCD-85D1-C3FF92247865 Q52659305-2CD94176-55C8-4455-811E-14EBC0B8E4FB Q57259399-677399E4-A245-4F38-AEEC-5AC55B832A0E Q57904586-B445141F-A9E4-43C1-946A-35231FD79EC9 Q58029880-B0922FE1-0F1E-4503-B568-B0767AFF2834

P2860

Identification of Amyloidogenic Light Chains Requires the Combination of Serum-Free Light Chain Assay with Immunofixation of Serum and Urine

http://www.wikidata.org/entity/Q58030328

description

im Januar 2009 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 08 January 2009

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в січні 2009

@uk

name

Identification of Amyloidogeni ...... unofixation of Serum and Urine

@en

Identification of Amyloidogeni ...... unofixation of Serum and Urine

@nl

type

label

Identification of Amyloidogeni ...... unofixation of Serum and Urine

@en

Identification of Amyloidogeni ...... unofixation of Serum and Urine

@nl

prefLabel

Identification of Amyloidogeni ...... unofixation of Serum and Urine

@en

Identification of Amyloidogeni ...... unofixation of Serum and Urine

@nl

P1433

Q58030328-1B3E4AE5-737E-4BB8-B091-946891252B4C

P1476

Q58030328-F105F6B8-9E5D-4C42-BE5F-5D577DC761CE

P2093

Q58030328-4716B242-4AF2-4BE5-B5C2-FCC6665CA0C7

Q58030328-5816F5B3-ADB9-4D08-AF3C-831676E2D8F3

Q58030328-6912E1E5-12CE-4CB6-AB80-3C6D2A8F5B09

Q58030328-6D18C11C-A035-4CD4-A0B5-E93AC94561A7

Q58030328-72CA9B32-A255-46F7-B41B-F67D68120FEB

Q58030328-751696A8-1E0E-4112-B29C-A4C1022C9271

Q58030328-7EED6FA1-9116-4784-84F3-AF62935ADF27

Q58030328-DC9F06D6-7B2C-463A-9E3D-9BB869413FB6

Q58030328-DCEA7705-FEA7-45B3-95B8-CEF64FCA4040

Q58030328-E471AECB-D9F0-46B0-A289-FB0514BD905B

P304

Q58030328-2B9E7881-EE0C-48F0-8C5B-6A9C8FED2759

P31

Q58030328-CBB8B77E-EACC-481D-8A25-911DE741233E

P356

Q58030328-D9E74F81-64C4-4D48-BA5D-39E40FC8140C

P407

Q58030328-3854DFF8-0A67-49F0-B8CA-5B56A18AF7D8

P433

Q58030328-3E2E511F-B4C2-407B-BBE7-89FC28C7DE1E

P478

Q58030328-815D2A1D-9780-4155-9C04-CFBFE17AB04D

P50

Q58030328-005E1F55-C805-4FEF-9297-1FB21CBA7990

Q58030328-012D0C88-62BB-41AC-86E7-763B7BA26423

Q58030328-09DD6E87-189C-4953-8619-0685CA10C27F

Q58030328-4EFFE356-B476-43CB-B0EC-3BE6CE9FDDD6

Q58030328-EB4E2E52-DF37-4EBB-AF3A-98E6A388FA4F

P577

Q58030328-86D606E2-4456-490C-91B1-6412D495E7E9

P698

Q58030328-6DC3478E-89F6-448C-80A6-B5F3FE3E0282

P356

CLINCHEM.2008.117143

P1433

Clinical Chemistry

P1476

Identification of amyloidogeni ...... unofixation of serum and urine

@en

P2093

Gabriele Sarais

http://www.w3.org/2001/XMLSchema#string

Gabriella Righetti

http://www.w3.org/2001/XMLSchema#string

Gian Vico Melzi D'Eril

http://www.w3.org/2001/XMLSchema#string

Laura Verga

http://www.w3.org/2001/XMLSchema#string

Maddalena Marini

http://www.w3.org/2001/XMLSchema#string

Maria Stella Graziani

http://www.w3.org/2001/XMLSchema#string

Paola Russo

http://www.w3.org/2001/XMLSchema#string

Remigio Moratti

http://www.w3.org/2001/XMLSchema#string

Riccardo Albertini

http://www.w3.org/2001/XMLSchema#string

Simona Casarini

http://www.w3.org/2001/XMLSchema#string

P304

499-504

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1373/CLINCHEM.2008.117143

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P50

Giovanni Palladini

Giampaolo Merlini

Francesca Lavatelli

P577

2009-01-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19131635

http://www.w3.org/2001/XMLSchema#string